Market cap: $
Exchange: NAS
Sector: Health Technology
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology. It is focused on the development and commercialization of small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel.
Company Name
Ayala Pharmaceuticals Inc
Average Volume (10 days)
0
Average Volume (30 days)
0
Moving Average (50 days)
$0
Moving Average (200 days)
$0
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
0
Shares Outstanding
14,820,727
52-Week High Split Adjust Only
0
52-Week Low Split Adjust Only
0
Employee Count
35
Beta
0
Next Earnings Date
TTM Dividend Rate Per Share
0
Past 5 days
0%
Past 30 days
0%
Past 3 months
0%
Past 6 months
0%
Past year
0%
Past 2 years
0%
Past 5 years
0%
Max % Change
0%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Ayala Pharmaceuticals Inc | AYLA | n/a | n/a | 3.3 | n/a | n/a |
| Peer Avg | N/A | n/a | n/a | -0.7 | n/a | n/a |
| Ovid Therapeutics Inc | OVID | n/a | n/a | 2.0 | n/a | n/a |
| Oyster Point Pharma Inc | OYST | n/a | n/a | -4.9 | n/a | n/a |